Get the full Kasvu Therapeutics company profile
Access contacts, investors, buying signals & more
Kasvu Therapeutics has raised $34.3M in Series A funding. The company is developing small molecule neuroplastogens - drugs designed to act quickly and lastingly on neuroplasticity without triggering hallucinations.
Kasvu says its compounds are aimed at diseases where neuronal connectivity is altered, and it's pursuing both first- and best-in-class positions in the space. The company did not disclose its investors.
Kasvu Therapeutics goes after a different neuroplasticity target to treat depression Kasvu Therapeutics goes after a different neuroplasticity target to treat depression The start-up has raised $34 million for its novel approach to replicating the benefits of psychedelics by Sarah Braner The latest chemistry news, including important research advances, business and policy trends, chemical safety practices, career guidance, and more.
The Finnish start-up Kasvu Therapeutics has raised €30 million ($34 million) in series A financing to support its work developing nonhallucinogenic small molecules to treat neuropsychiatric disorders. Founded in 2023, Kasvu is based on Eero Castrén and Ilpo Vattulainen ’s research at the University of Helsinki. Their work focused on tropomyosin receptor kinase B (TrkB) and its role in neuroplastic
Verda
Verda Cloud Oy is a cloud service provider geared towards AI, providing raw computational power at affordable rates.
$189.0M Series b
1 day ago
LignoSphere
LignoSphereTM is a new technology to make wood-based, ecological, carbon neutral adhesives, coatings and paints from lignin.
$1.4M Pre-seed
8 days ago
Zero
A powerful and flexible CRM & sales automation toolkit for tomorrow's high-growth companies. Built on a unified customer data layer powered by AI. Sign up for our waitlist to hear from us soon.
Largest funding rounds in Biotechnology on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Shockwave Medical United States | Unknown | $13.1B | 2y ago |
| 2 |  NeuroEM Therapeutics United States | Unknown |
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  AD System Asia Thailand | Series a | $9.6M | today |
| 2 |  Flatkey United States | Series a | $10.0M | today |
$10.4M Seed
9 days ago
| $7.2B |
| 2y ago |
| 3 |  Illumina United States | Unknown | $7.1B | 2y ago |
| 4 |  GRAIL United States | Unknown | $7.1B | 2y ago |
| 5 |  RemeGen Biosciences United States | Grant | $5.6B | 8mo ago |
| 3 |
 givestar United Kingdom |
| Series a |
| $12.0M |
| today |
| 4 |  3cat Malaysia | Series a | $4.0M | 1d ago |
| 5 |  Ramona United States | Series a | $25.0M | 1d ago |
Trusted by 200+ sales teams
See who invested in Kasvu Therapeutics and reach their contacts directly.
Start free trial
ivyclip
Recently received
EAPRO Global Ltd
Recently received
StandardX
Recently received
